Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Rawcliffe
L. Rawcliffe
Medicine
Internal medicine
Marketing
Organic chemistry
Marketing authorization
3
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An optimised versus standard dosing regimen of vancomycin in infants with Gram-1 positive sepsis (NeoVanc): a multi-centre randomised, open-label, phase IIb, non-inferiority trial
2021
The Lancet Child & Adolescent Health
L Hill
MN Clements
Mark A. Turner
D. Dona
Irja Lutsar
E. Jacqz-Aigrain
Paul T. Heath
Emmanuel Roilides
L. Rawcliffe
C. Alonso Díaz
Eugenio Baraldi
A. Dotta
M.-L. Ilmoja
A Mahaveer
Tuuli Metsvaht
G. Mitsiakos
Papevangelou
Kosmas Sarafidis
As Walker
Mike Sharland
Show All
Source
Cite
Save
Citations (0)
Buccolam: the first centralized paediatric use marketing authorization.
2013
International Journal of Pharmaceutics
L. Rawcliffe
J Winslade
S.E. Conroy
Show All
Source
Cite
Save
Citations (2)
Creatinuria and Testicular Damage due to 2-Methoxyethanol in the Rat
1988
Human & Experimental Toxicology
L. Rawcliffe
John A. Timbrell
J. Turton
Dianne M. Creasy
Show All
Source
Cite
Save
Citations (0)
1